NCI Thesaurus OBO Edition
3627 terms(s) returned
| Term Type: | Record: 3601 to 3627 of 3627 Records | Page: 73 of 73, First Previous Next Last | Show Records Per Page |
- iNOS Dimerization Inhibitor FK-330
- iPSC-derived Allogeneic Anti-CD19 1XX-CAR T-cells FT819
- iPSC-derived Allogeneic Anti-HER2 CAR T-cells FT825
- iPSC-derived Anti-BCMA CAR/CD16/IL-15RF-expressing CD38-eliminated NK Cells FT576
- iPSC-derived Anti-CD19 CAR/CD16/IL-15RF/ADR-expressing CD38-eliminated NK Cells FT522
- iPSC-derived CD16-expressing Natural Killer Cells FT516
- iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596
- iPSC-derived CD16/IL-15RF-expressing CD38-eliminated NK Cells FT538
- iPSC-derived MSCs CYP-001
- iPSC-derived Natural Killer Cells FT500
- iRECIST Complete Response
- iRECIST Confirmed Progressive Disease
- iRECIST Partial Response
- iRECIST Stable Disease
- iRECIST Unconfirmed Progressive Disease
- idic(X)(q13)
- in subset
- inv(16)
- inv(22q12)
- inv(8;8)(q13;q21)
- inv(X)(p11.4;p11.22)
- irCR Thrombosis
- irPD Thrombosis
- irPR Thrombosis
- irSD Thrombosis
- isVersionOf
- itRECIST Goldmacher 2020 Oncology Response Criteria
